Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

The First Announcement for the 11th National Workshop on Differential Diagnosis of Benign and Malignant Lymphoid Lesions and the Lymphoma Academic Conference

Continue reading
06 2 月

Immunohistochemical Differentiation of Carcinoma, Mesothelioma, and Reactive Mesothelial Cells

Continue reading
06 2 月

Get Lost, Tumor: EB Virus’s Self-Narrative – The Stomach Cancer Chapter

Continue reading
06 2 月

Table 3. Breast Cancer Genotyping Based on Immunohistochemical Antibodies

Continue reading
06 2 月

Differential Diagnosis of Small Round Blue Cell Tumors

Continue reading
06 2 月

Napoleon’s Hat: A Unique Diagnostic Clue for Reactive Hyperplastic Alveolar Cells

Continue reading
06 2 月

Precautions for Antigen Enzyme Digestion and Retrieval in Paraffin Tissue Sections

Continue reading
06 2 月

Forging Ahead with Excellence: Maxin Successfully Listed as National-Level Specialized and Sophisticated “Little Giant” Enterprise

Continue reading
06 2 月

Cancer Talk: The “Fortunate” Thyroid Cancer?

Continue reading
06 2 月

Table 8. Immunohistochemical Differential Chart for Primary Malignant Epithelial Tumors of the Ovary

Continue reading
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar